Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 428618, 10 pages
http://dx.doi.org/10.1155/2010/428618
Research Article

Dual Effect of Neutrophils on pIgR/Secretory Component in Human Bronchial Epithelial Cells: Role of TGF- 𝛽

Institute of Experimental and Clinical Research, Pole Pneumology, ENT and Dermatology, Cliniques Universitaires St-Luc, Université Catholique de Louvain (UCL), Brussels B-1200, Belgium

Received 2 December 2009; Revised 17 May 2010; Accepted 24 May 2010

Academic Editor: Susan A. Rotenberg

Copyright © 2010 Céline Ratajczak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Pilette, S. R. Durham, J. P. Vaerman, and Y. Sibille, “Mucosal immunity in asthma and chronic obstructive pulmonary disease: a role for immunoglobulin A?” Proceedings of the American Thoracic Society, vol. 1, no. 2, pp. 125–135, 2004. View at Google Scholar · View at Scopus
  2. P. Brandtzaeg, “Role of secretory antibodies in the defence against infections,” International Journal of Medical Microbiology, vol. 293, no. 1, pp. 3–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. C. S. Kaetzel, “The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces,” Immunological Reviews, vol. 206, pp. 83–99, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. M. Mannino and A. S. Buist, “Global burden of COPD: risk factors, prevalence, and future trends,” Lancet, vol. 370, no. 9589, pp. 765–773, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. L. Curtis, C. M. Freeman, and J. C. Hogg, “The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research,” Proceedings of the American Thoracic Society, vol. 4, no. 7, pp. 512–521, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. Pilette, B. Colinet, and B. Colinet, “Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD,” European Respiratory Journal, vol. 29, no. 5, pp. 914–922, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C. Pilette, V. Godding, and V. Godding, “Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 1, pp. 185–194, 2001. View at Google Scholar · View at Scopus
  8. C. Pilette, Y. Ouadrhiri, F. Dimanche, J.-P. Vaerman, and Y. Sibille, “Secretory component is cleaved by neutrophil serine proteinases but its epithelial production is increased by neutrophils through NF-κB- and p38 mitogen-activated protein kinase-dependent mechanisms,” American Journal of Respiratory Cell and Molecular Biology, vol. 28, no. 4, pp. 485–498, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. R. Bruggisser, K. Von Daeniken, G. Jundt, W. Schaffner, and H. Tullberg-Reinert, “Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay,” Planta Medica, vol. 68, no. 5, pp. 445–448, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. V. M. Keatings and P. J. Barnes, “Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 2, pp. 449–453, 1997. View at Google Scholar
  11. G. R. Grotendorst, G. Smale, and D. Pencev, “Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils,” Journal of Cellular Physiology, vol. 140, no. 2, pp. 396–402, 1989. View at Google Scholar
  12. R. A. Fava, N. J. Olsen, and N. J. Olsen, “Transforming growth factor β1 (TGF-β1) induced neutrophil recruitment to synovial tissues: implications for TGF-β-driven synovial inflammation and hyperplasia,” Journal of Experimental Medicine, vol. 173, no. 5, pp. 1121–1132, 1991. View at Google Scholar
  13. P. van Vlasselaer, J. Punnonen, and J. E. De Vries, “Transforming growth factor-β directs IgA switching in human B cells,” Journal of Immunology, vol. 148, no. 7, pp. 2062–2067, 1992. View at Google Scholar
  14. T. M. McIntyre, M. R. Kehry, and C. M. Snapper, “Novel in vitro model for high-rate IgA class switching,” Journal of Immunology, vol. 154, no. 7, pp. 3156–3161, 1995. View at Google Scholar
  15. O. Sacco, D. Romberger, A. Rizzino, J. D. Beckmann, S. I. Rennard, and J. R. Spurzem, “Spontaneous production of transforming growth factor-β2 by primary cultures of bronchial epithelial cells. Effects on cell behavior in vitro,” Journal of Clinical Investigation, vol. 90, no. 4, pp. 1379–1385, 1992. View at Google Scholar
  16. R. D. Wang, J. L. Wright, and A. Churg, “Transforming growth factor-β1 drives airway remodeling in cigarette smoke-exposed tracheal explants,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 4, pp. 387–393, 2005. View at Publisher · View at Google Scholar · View at PubMed
  17. W. I. de Boer, A. van Schadewijk, J. K. Sont, H. S. Sharma, J. Stolk, P. S. Hiemstra, and J. H. J. M. Van Krieken, “Transforming growth factor β1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 6, pp. 1951–1957, 1998. View at Google Scholar
  18. H. Takizawa, M. Tanaka, and M. Tanaka, “Increased expression of transforming growth factor-β1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD),” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 6, pp. 1476–1483, 2001. View at Google Scholar
  19. B.-L. Luo, R.-C. Niu, J.-T. Feng, C.-P. Hu, X.-Y. Xie, and L.-J. Ma, “Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-β/Smads signaling pathways,” Archives of Medical Research, vol. 39, no. 4, pp. 388–396, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. A. L. Sullivan, T. Dafforn, P. S. Hiemstra, and R. A. Stockley, “Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex,” Respiratory research, vol. 9, p. 60, 2008. View at Google Scholar
  21. J. M. Sethi and C. L. Rochester, “Smoking and chronic obstructive pulmonary disease,” Clinics in Chest Medicine, vol. 21, no. 1, pp. 67–86, 2000. View at Google Scholar
  22. I. Rahman and I. M. Adcock, “Oxidative stress and redox regulation of lung inflammation in COPD,” European Respiratory Journal, vol. 28, no. 1, pp. 219–242, 2006. View at Publisher · View at Google Scholar · View at PubMed
  23. V. L. Kinnula, L. Chang, J. I. Everitt, and J. D. Crapo, “Oxidants and antioxidants in alveolar epithelial type II cells: In situ, freshly isolated, and cultured cells,” American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 262, no. 1, pp. L69–L77, 1992. View at Google Scholar
  24. V. L. Kinnula, L. Y. Chang, Y. S. Ho, and J. D. Crapo, “Hydrogen peroxide release from alveolar macrophages and alveolar type II cells during adaptation to hyperoxia in vivo,” Experimental Lung Research, vol. 18, no. 5, pp. 655–673, 1992. View at Google Scholar
  25. I. Jaspers, J. M. Samet, S. Erzurum, and W. Reed, “Vanadium-induced κB-dependent transcription depends upon peroxide-induced activation of the p38 mitogen-activated protein kinase,” American Journal of Respiratory Cell and Molecular Biology, vol. 23, no. 1, pp. 95–102, 2000. View at Google Scholar
  26. Y. Q. Xiao, C. G. Freire-de-Lima, W. J. Janssen, K. Morimoto, D. Lyu, D. L. Bratton, and P. M. Henson, “Oxidants selectively reverse TGF-β suppression of proinflammatory mediator production,” Journal of Immunology, vol. 176, no. 2, pp. 1209–1217, 2006. View at Google Scholar
  27. C. C. Taggart, S.-A. Cryan, and S.-A. Cryan, “Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding,” Journal of Experimental Medicine, vol. 202, no. 12, pp. 1659–1668, 2005. View at Publisher · View at Google Scholar · View at PubMed
  28. I. M. Adcock and G. Caramori, “Kinase targets and inhibitors for the treatment of airway inflammatory diseases: the next generation of drugs for severe asthma and COPD?” BioDrugs, vol. 18, no. 3, pp. 167–180, 2004. View at Publisher · View at Google Scholar
  29. T. Renda, S. Baraldo, and S. Baraldo, “Increased activation of p38 MAPK in COPD,” European Respiratory Journal, vol. 31, no. 1, pp. 62–69, 2008. View at Publisher · View at Google Scholar · View at PubMed
  30. P. J. Barnes, “Novel signal transduction modulators for the treatment of airway diseases,” Pharmacology and Therapeutics, vol. 109, no. 1-2, pp. 238–245, 2006. View at Publisher · View at Google Scholar · View at PubMed
  31. D. C. Underwood, R. R. Osborn, and R. R. Osborn, “SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung,” American Journal of Physiology, vol. 279, no. 5, pp. L895–L902, 2000. View at Google Scholar
  32. J.-M. Sallenave, “The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease,” Respiratory Research, vol. 1, no. 2, pp. 87–92, 2000. View at Publisher · View at Google Scholar
  33. R. Pfundt, M. Wingens, M. Bergers, M. Zweers, M. Frenken, and J. Schalkwijk, “TNF-α and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway,” Archives of Dermatological Research, vol. 292, no. 4, pp. 180–187, 2000. View at Google Scholar